Old Web
English
Sign In
Acemap
>
Paper
>
Subsequent entry biologic (biosimilar) monoclonal antibodies in Canada: A review of key regulatory issues and lessons learned
Subsequent entry biologic (biosimilar) monoclonal antibodies in Canada: A review of key regulatory issues and lessons learned
2016
Bradley Scott Wang J
Klein A
Keywords:
Antibody
Biosimilar
Immunology
Pharmacology
Monoclonal
Monoclonal antibody
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]